Company intelligence / Profile preview

Ventures Partners

Chicago, Illinois, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

ARCH Venture Partners is a premier venture capital firm that specializes in founding and investing in ground-breaking life science and technology companies. The firm is known for its "company creation" model, often partnering with leading scientists and research institutions to build startups around disruptive technologies. ARCH has been instrumental in the development of numerous high-profile biotech companies, including Illumina, Alnylam Pharmaceuticals, Juno Therapeutics, and Grail. Their investment strategy focuses on high-risk, high-reward innovations in genomics, cell therapy, synthetic biology, and infectious diseases.

Industry: Investors

Partnerships

University of ChicagoMayo ClinicHarvard UniversityMassachusetts Institute of Technology

Beyond the preview

Go deeper on Ventures Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ventures Partners.

Explore the full profile